Biagio Nicolosi

Dr. Biagio Nicolosi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2024 in infermieristica journal
Verified
Journal Article
Open access
PDF file
MMMarina Maffeo
Marina Maffeo
ISIrene Sartorio
Irene Sartorio
MFMaria Elena Fiani
Maria Elena Fiani
Biagio NicolosiBiagio Nicolosi
Biagio Nicolosi
DCDaniele Ciofi
Daniele Ciofi
Background: Pediatric palliative care (CPP) is defined as active and holistic care of the child's body, mind and spirit, actively supporting the centrality and role of the family. They have as their primary objective the improvement of the quality of life of children and their families, supporting them in treatment choices. CPPs should be planned at the time of diagnosis, in order to be able to initiate the patient and family early on to a type of care that responds to the multiple needs that the situation entails, without precluding concomitant curative therapy. In fact, it has been shown that they are all the more effective the earlier they are integrated into the child's treatment plan. However, despite the international recognition of CPPs as an integral part of the right to health, implementation and effective access to such services remain limited in many contexts, including Italy. challenges to CPPs integration are multiple and include the complexity of clinical conditions, lack of training of healthcare professionals, regulatory and regional politicy issues, and socio-cultural barriers.Aim: The primary aim of this scoping review is to investigate the current landscape of PPCs for children and young people with life-limiting non-oncological conditions in Italy and worldwide in terms of benefits, eligibility, impact on the family and the barriers associated with treatment.Materials and method: A scoping review was performed between September 2023 and January 2024 following the PRISMA guidelines using the keywords “pediatric palliative care” AND “chronic disease/barrier/eligibility/parents.Results: Ten full-text articles met the inclusion criteria. The major studies were quantitative, cross sectional. The finding demonstrates that early inclusion of complex chronic non-oncological patients in palliative care programs leads to greater patient and family satisfaction, reducing emotional burden and improving communication and treatment planning. Parents experience stress and financial difficulties. Parent psychological distress was associated with parent-reported patient symptoms and financial difficulty. Major challenges include the lack of support networks and training in palliative care, along with legal and economic issues.Conclusions: While there is growing recognition of the importance of CPP, further efforts are needed to address challenges in accessing and integrating services, as well as meeting the needs of patients, families and healthcare professionals working in this field. Improving knowledge and awareness about CPP can help overcome barriers to accessing services and improve the quality of care provided to pediatric patients and their families.

2 September 2025 in Journal of Wound Care
Verified
Journal Article
Closed access
Biagio NicolosiBiagio Nicolosi
Biagio Nicolosi
EPEustachio Parente
Eustachio Parente
APAlessio Petronici
Alessio Petronici
LFLeonardo Fioravanti
Leonardo Fioravanti
SCSimona Cavalieri
Simona Cavalieri
GCGuido Ciprandi
Guido Ciprandi
Objective: Moisture-associated skin damage (MASD) is a significant concern in the paediatric population, particularly among neonates, who exhibit the highest incidence due to their highly sensitive and fragile skin. The aim of the study was to identify the most effective treatment. Method: A retrospective observational study was conducted at Meyer Children's Hospital IRCCS, Florence, Italy. Data from infants admitted to the neonatal intensive care unit of the hospital were collected from electronic health records. Demographic, clinical and nursing data were analysed to identify the key clinical features of MASD lesions, including their severity, healing time, and the relationship between MASD lesions and treatment approaches. Results: The cohort comprised 102 infants (mean age 2.92 months). Incontinence-associated dermatitis (IAD) accounted for the majority (78.4%) of MASD lesions. Among patients with IAD, most exhibited persistent redness (26.3%) or skin loss (47.5%) without clinical signs of infection. In contrast, peristomal MASD cases constituted 21.6% of the total, with the majority classified according to the Study on Peristomal Skin Alterations (SACS) 2.0 as L2 erosive lesions (63.6%), predominantly occurring in quadrants 2, 3 or 5. A novel treatment (Vulnamin; Professional Dietetics S.p.A., Italy) was used to manage MASD lesions in 64.7% of patients. This innovative treatment significantly (p<0.001) reduced healing time by an average of 2.4 days and decreased the odds of relapse by 5.3 times compared with traditional treatments. Conclusion: The findings of this study showed that use of effective MASD therapies can reduce healing time and relapse rate, leading to decreased nursing hours and associated costs.

9 May 2025 in Journal of Clinical Nursing
Verified
Journal Article
Open access
Biagio NicolosiBiagio Nicolosi
Biagio Nicolosi
ENElisa Neri
Elisa Neri
LFLeonardo Fioravanti
Leonardo Fioravanti
SLSilvia Leoncini
Silvia Leoncini
CFClaudio De Felice
Claudio De Felice
AMAlessandra Mugnaini
Alessandra Mugnaini
Aim: To assess the validity of a modified Neonatal Skin Risk Assessment scale (Dev‐NSARS) for neonatal pressure injuries (PIs) in the neonatal intensive care unit (NICU) and neonatal sub‐intensive care unit (NICU‐Sub) environment. Background: Medical devices are the leading cause of pressure injuries (PIs) in neonates, a key cause of morbidity in neonatology, significantly impacting the length of stay (LOS) and public hospital resources. Methods: The Dev‐NSRAS scale, considering the presence of medical devices, was tested on a national multicenter prospective study on newborns. The discrimination power of the Dev‐NSRAS scale was compared to that of the more commonly used Glamorgan scale. Results: Nine newborns (6.6%) developed PIs, with a total of 16 injuries, 75% (12 out of 16) of which were device related. Newborns with postconceptional age ≤ 30.8 weeks were at higher risk of developing PIs. First 24‐h total Dev‐NSRAS scores were compared with first 24‐h Glamorgan scores, to obtain and compare respective sensitivity and specificity. During the first 24 h from admission, a very good discriminative performance was evidenced for Dev‐NSRAS ≤ 11 (AUC 0.921, 95% CI: 0.899–0.940, p < 0.0001; 81.6% sensitivity and 93.6% specificity) as compared to a moderate discriminative performance shown by a Glamorgan score > 28 (AUC 0.752, 95% CI: 0.634–0.660, p < 0.0001; 92.1% sensitivity and 65.5% specificity). Conclusions: Early application (i.e., in the first day from hospital admission) of Dev‐NSRAS by the nursing personnel shows excellent accuracy in predicting the risk of developing PUs in newborns admitted to NICU and NICU‐Sub, as compared to the Glamorgan scale. Reporting Method: The STROBE statement for cohort observational studies was used as the reference reporting method. Impact: The study addressed the lack of a risk assessment scale for pressure injuries in neonates. Development and testing of a scale that demonstrated high sensitivity and specificity in the early prediction of pressure injury risk in neonates within the first 24 h. The research will have an impact in NICUs and NICU‐Sub units, enabling nurses to plan personalised care to prevent pressure injuries in neonates, thereby reducing the length of hospital stays and overall healthcare costs. Contribution: Introduce a validated scale for improving neonatal pressure injury prevention worldwide. Enhance early detection tools, reduce hospital stays and global costs. Protocol Registration: The study protocol has been approved by the Paediatric Tuscany Region Ethical Committee (date: 18 January 2021; protocol code 18/2021).

31 December 2024 in infermieristica journal
Verified
Journal Article
Open access
PDF file
Biagio NicolosiBiagio Nicolosi
Biagio Nicolosi
EPEustachio Parente
Eustachio Parente
IFIrene Fontani
Irene Fontani
SISabina Idrizaj
Sabina Idrizaj
DSDaiana Stringi
Daiana Stringi
CCCiofi Ciofi
Ciofi Ciofi
Background. Skin injuries in hospitalized pediatric patients can slow recovery, increase infection risk, pain, stress, length of stay, and healthcare costs, while reducing family quality of life. The prevalence and incidence of these injuries vary by environment, comorbidities, and specific pathologies. Objective. To identify the main risk factors related to skin lesions in hospitalized children Methods. This retrospective, observational, monocentric study aims to identify the main risk factors for skin injuries in hospitalized children. Results. A study of 880 hospitalized children aged 0-17 from January 2019 to December 2020 found that 133 developed skin injuries. Factors increasing risk included longer hospital stays, comorbidities, forced bed rest, and the number of medical devices. Each additional hospitalization day and lower weight raised the risk. Continence was protective. Injuries mainly affected the perineum, upper limbs, face, lower limbs, abdomen, and occiput. These findings emphasize the need for tailored prevention strategies for pediatric patients due to their unique characteristics. Conclusions. This study underscores the need for further research to develop effective prevention protocols specifically for pediatric populations, emphasizing the role of comprehensive risk factor assessment and resource allocation to mitigate skin injury risks in hospitalized children.

14 April 2025 in Nursing Reports
Verified
Journal Article
Open access
PDF file
MSMarica Soddu
Marica Soddu
Andrea De VitoAndrea De Vito
Andrea De Vito
Giordano MadedduGiordano Madeddu
Giordano Madeddu
Biagio NicolosiBiagio Nicolosi
Biagio Nicolosi
MPMARIA PROVENZANO
MARIA PROVENZANO
Felice CurcioFelice Curcio
Felice Curcio
Background/Objectives: The advent of large language models (LLMs), like platforms such as ChatGPT, capable of generating quick and interactive answers to complex questions, opens the way for new approaches to training healthcare professionals, enabling them to acquire up-to-date and specialised information easily. In nursing, they have proven to support clinical decision making, continuing education, the development of care plans and the management of complex clinical cases, as well as the writing of academic reports and scientific articles. Furthermore, the ability to provide rapid access to up-to-date scientific information can improve the quality of care and promote evidence-based practice. However, their applicability in clinical practice requires thorough evaluation. This study evaluated the accuracy, completeness and safety of the responses generated by ChatGPT-4 on pressure injuries (PIs) in infants. Methods: In January 2025, we analysed the responses generated by ChatGPT-4 to 60 queries, subdivided into 12 main topics, on PIs in infants. The questions were developed, through consultation of authoritative documents, based on their relevance to nursing care and clinical potential. A panel of five experts, using a 5-point Likert scale, assessed the accuracy, completeness and safety of the answers generated by ChatGPT. Results: Overall, over 90% of the responses generated by ChatGPT-4o received relatively high ratings for the three criteria assessed with the most frequent value of 4. However, when analysing the 12 topics individually, we observed that Medical Device Management and Technological Innovation were the topics with the lowest accuracy scores. At the same time, Scientific Evidence and Technological Innovation had the lowest completeness scores. No answers for the three criteria analysed were rated as completely incorrect. Conclusions: ChatGPT-4 has shown a good level of accuracy, completeness and safety in addressing questions about pressure injuries in infants. However, ongoing updates and integration of high-quality scientific sources are essential for ensuring its reliability as a clinical decision-support tool.

19 June 2025 in Children
Verified
Journal Article
Open access
PDF file
Biagio NicolosiBiagio Nicolosi
Biagio Nicolosi
EBEleonora Bastarelli
Eleonora Bastarelli
MGMirco Gregorini
Mirco Gregorini
GUIDO CIPRANDIGUIDO CIPRANDI
GUIDO CIPRANDI
Background/Objectives: Pediatric skin injuries represent a clinical challenge, especially in cases with complex etiology or with severe pain. Blue light is an emerging technology with potential application in pediatric wound care. The aim of this case series was to describe the clinical use of blue light in pediatric patients with injuries of varying etiologies and mechanisms, and to assess its long-term effectiveness and sustainability in treatment. Methods: Twelve hospitalized pediatric patients (0–12 years old) with skin injuries were included in this case series. The etiologies of wounds treated with photobiomodulation were incontinence-associated dermatitis, peristomal injuries, and pressure injuries. The injuries were assessed using specific classification tools and pain scales. The wounds were treated every three days using a medical device that emits blue light (410–430 nm). When necessary, wounds were also treated with appropriate dressings. Results: All injuries responded positively to photobiomodulation therapy and showed a rapid resolution of inflammation. Complete wound resolution was achieved in 11 of 12 cases. The average healing time was 3.7 days. Four injuries achieved resolution with only one application of blue light. Scores from the pain perception scales showed that the blue light treatment was well tolerated by pediatric patients, showing high parental compliance. No side effects or adverse events were observed. Conclusions: Blue light photobiomodulation proved to be a safe, well-tolerated, and effective technology in the treatment of pediatric skin injuries, with good acceptance by young patients and families. More structured clinical trials would be needed to validate the efficacy of blue light in pediatric injuries.